Genetically engineered mice for combinatorial cardiovascular optobiology.
Frank K LeeJane C LeeBo ShuiShaun ReiningMegan JibilianDavid M SmallJason S JonesNathaniel H Allan-RahillMichael Re LamontMegan A RizzoSendoa TajadaManuel F NavedoLuis Fernando SantanaNozomi NishimuraMichael I KotlikoffPublished in: eLife (2021)
Optogenetic effectors and sensors provide a novel real-time window into complex physiological processes, enabling determination of molecular signaling processes within functioning cellular networks. However, the combination of these optical tools in mice is made practical by construction of genetic lines that are optically compatible and genetically tractable. We present a new toolbox of 21 mouse lines with lineage-specific expression of optogenetic effectors and sensors for direct biallelic combination, avoiding the multiallelic requirement of Cre recombinase -mediated DNA recombination, focusing on models relevant for cardiovascular biology. Optogenetic effectors (11 lines) or Ca2+ sensors (10 lines) were selectively expressed in cardiac pacemaker cells, cardiomyocytes, vascular endothelial and smooth muscle cells, alveolar epithelial cells, lymphocytes, glia, and other cell types. Optogenetic effector and sensor function was demonstrated in numerous tissues. Arterial/arteriolar tone was modulated by optical activation of the second messengers InsP3 (optoα1AR) and cAMP (optoß2AR), or Ca2+-permeant membrane channels (CatCh2) in smooth muscle (Acta2) and endothelium (Cdh5). Cardiac activation was separately controlled through activation of nodal/conducting cells or cardiac myocytes. We demonstrate combined effector and sensor function in biallelic mouse crosses: optical cardiac pacing and simultaneous cardiomyocyte Ca2+ imaging in Hcn4BAC-CatCh2/Myh6-GCaMP8 crosses. These experiments highlight the potential of these mice to explore cellular signaling in vivo, in complex tissue networks.
Keyphrases
- high resolution
- induced apoptosis
- left ventricular
- smooth muscle
- type iii
- high fat diet induced
- cell cycle arrest
- low cost
- single cell
- gene expression
- poor prognosis
- intellectual disability
- regulatory t cells
- endoplasmic reticulum stress
- heart failure
- nitric oxide
- cell death
- cell therapy
- single molecule
- metabolic syndrome
- cell proliferation
- climate change
- circulating tumor
- stem cells
- dna methylation
- binding protein
- adipose tissue
- dna repair
- photodynamic therapy
- angiotensin ii
- wild type
- atrial fibrillation
- squamous cell carcinoma
- vena cava
- fluorescence imaging
- pulmonary embolism